MedTrace Logo

Comparison of Gastric By-Pass and Optimized Medical Treatment in Obese Diabetic Patients

NCT01501201 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2026-05-22

No results posted yet for this study

Summary

The objectives are to compare the results of the Gastric By-Pass (GBP) to that of optimized medical therapy in patients with obesity and poorly controlled type 2 diabetes in terms of mortality, weight loss, glycemic control, quality of life, cost, cost-effectiveness and cost utility of these two strategies.

Conditions

Interventions

PROCEDURE

Gastric By-Pass

Bariatric surgery laparoscopic Roux-en-Y Gastric Bypass (RYGBP)

DRUG

optimized medical management

group receiving an optimized medical management, among patients with obesity and poorly controlled type 2 diabetes

Sponsors & Collaborators

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • Francois Pattou, Professor · University Hospital of Lille

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-08
Primary Completion
2019-09-27
Completion
2019-09-27

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01501201 on ClinicalTrials.gov